May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Expression of Chemokine Receptors in Uveal Melanoma
Author Affiliations & Notes
  • A.P. Moulin
    Pathology, University Institute of Pathology, Lausanne, Switzerland
  • P. Yan
    Pathology, University Institute of Pathology, Lausanne, Switzerland
  • D. Rimoldi
    Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland
  • S. Leyvraz
    Oncology, Multidisciplinary Oncology Centre (CePO), CHUV/Lausanne, Switzerland
  • A. Schalenbourg
    Ophthalmology, Jules Gonin Eye Hopsital, Lausanne, Switzerland
  • L. Zografos
    Ophthalmology, Jules Gonin Eye Hopsital, Lausanne, Switzerland
  • F.T. Bosman
    Pathology, University Institute of Pathology, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships  A.P. Moulin, None; P. Yan, None; D. Rimoldi, None; S. Leyvraz, None; A. Schalenbourg, None; L. Zografos, None; F.T. Bosman, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2215. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A.P. Moulin, P. Yan, D. Rimoldi, S. Leyvraz, A. Schalenbourg, L. Zografos, F.T. Bosman; Expression of Chemokine Receptors in Uveal Melanoma . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2215.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Chemokine receptors are transmembrane G coupled proteins that might be involved in the directional metastatic migration of tumor cells to specific organs. CXCR4 and CCR7 have been implicated in the selective metastasis of cutaneous melanoma cells to lung and lymph node, respectively. CCR6 is expressed in metastases from colon, ovarian and thyroid carcinomas to the liver where its ligand, CCL20, is constitutively expressed. As uveal melanomas frequently metastasize to the liver, we hypothesized that specific chemokine receptors and their respective ligands might be involved in metastasis of uveal melanoma to the liver.

Methods: : Tissue microarrays were constructed using 100 non irradiated primary uveal melanomas and 84 liver metastases, as well as 12 non liver metastases, collected from the files of Jules Gonin Eye Hospital and Pathology Institute, University of Lausanne. Immunohistochemistry was performed using anti–human CXCR4, SDF1, CCR7, CCL21 and CCR6 antibodies.

Results: : CXCR4 expression was detected in 36% of primary uveal melanomas and in 63% of liver metastases but no expression was found in metastases to other organs, except for one pancreatic metastasis. SDF1 expression was detected in 3% of primary uveal melanomas and in 26% of liver metastases, as well as in pancreas, lymph node and breast metastases. CCR6 expression was observed in the majority of primary uveal melanomas and liver metastases (73 and 88%, respectively). In addition, CCR6 was also detected in 9 metastases to other organs (pancreas, thyroid, lymph node, skin and breast). CCR7 and CCL21 were neither detected in primary uveal melanoma, nor in the metastases.

Conclusions: : Chemokine receptors CCR6 and CXCR4 are expressed in a large number of primary uveal melanomas and in uveal melanoma metastases to the liver. CCR6 is also expressed in a small number of metastases to other organs. These findings form the basis for further studies on the potential involvement of CXCR4 and CCR6 in the selective metastasis of uveal melanoma to the liver.

Keywords: melanoma • pathology: human • immunohistochemistry 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×